Acumen Pharmaceuticals In... (ABOS)
1.65
0.04 (2.48%)
At close: Jan 17, 2025, 3:59 PM
1.65
0.00%
After-hours Jan 17, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -3.56 | -5.42 | -1.51 | -110.19 | -102.65 |
| PS Ratio | n/a | n/a | n/a | 562.01 | 475.58 |
| PB Ratio | 0.70 | 1.16 | 1.22 | -43.41 | -70.67 |
| P/FCF Ratio | -4.32 | -6.21 | -15.2 | -108.33 | -118.37 |
| P/OCF Ratio | -4.32 | -6.24 | -15.23 | -108.33 | -118.37 |
| OCF/S Ratio | n/a | n/a | n/a | -5.19 | -4.02 |
| Debt / Equity Ratio | 0.11 | 0.00 | n/a | n/a | n/a |
| Quick Ratio | 19.01 | 23.08 | 38.60 | 6.98 | 5.35 |
| Current Ratio | 19.01 | 23.08 | 38.60 | 6.98 | 5.35 |
| Asset Turnover | n/a | n/a | n/a | 0.03 | 0.23 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -0.2 | -0.21 | -0.81 | 0.39 | 0.69 |
| Return on Assets (ROA) | -0.17 | -0.21 | -0.79 | -0.16 | -1.07 |
| Return on Capital (ROIC) | -0.21 | -0.24 | 0.27 | -0.21 | -1.31 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | 99.44% | 99.49% |
| Net Profit Margin | n/a | n/a | n/a | -510.03% | -463.29% |
| Pretax Profit Margin | n/a | n/a | n/a | -510.1% | -465.94% |
| Operating Profit Margin | n/a | n/a | n/a | -550.97% | -459.93% |
| FCF Margin | n/a | n/a | n/a | -518.8% | -401.77% |
| EBITDA Margin | n/a | n/a | n/a | 40.88% | 7.01% |